Periodontal status in children with primary immunodeficiencies.


Journal

Journal of periodontal research
ISSN: 1600-0765
Titre abrégé: J Periodontal Res
Pays: United States
ID NLM: 0055107

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 22 12 2020
received: 23 06 2020
accepted: 15 03 2021
pubmed: 4 4 2021
medline: 13 7 2021
entrez: 3 4 2021
Statut: ppublish

Résumé

This study aimed to assess associations between neutrophil-related primary immunodeficiencies (PIDs) and the presence of periodontal disease and other oral diseases and response to periodontal treatment. Presence of neutrophil-related PIDs is thought to be a major risk factor for development of periodontitis. This study had both a cross-sectional and cohort design. Twenty-four children (age 4-16) with PIDs and 24 age-matched systemically healthy subjects received a dental clinical examination, including measures of probing pocket depths (PPD), clinical attachment loss (CAL) and bleeding on probing (BOP). Those found to be affected by periodontal disease were offered periodontal treatment and reassessed 6 months later. Diagnosis of PIDs was associated with increased odds of presence of periodontal disease (p = .008 adjusted for age, gender, plaque, OR = 10.0, 95% CI = 1.83-54.38) and with continuous measures of periodontal disease such as number of PPDs >4 mm, mean PPD and mean CAL (all p < .001) and BOP (p = .001). However, only 7 out of 24 children were diagnosed with periodontitis. PIDs were also associated with a history of oral ulcers (p = .001, OR 12.47, 95% CI 2.71-57.29). An improvement in periodontal parameters (PPD and CAL) was detected following oral hygiene instructions and non-surgical periodontal therapy. Although children affected by neutrophil-associated PIDs exhibited a higher prevalence of periodontal disease compared with systemically healthy children, severe periodontitis was rarely seen. This suggests that good systemic control of the PIDs may reduce their impact on the periodontium.

Sections du résumé

OBJECTIVE OBJECTIVE
This study aimed to assess associations between neutrophil-related primary immunodeficiencies (PIDs) and the presence of periodontal disease and other oral diseases and response to periodontal treatment.
BACKGROUND BACKGROUND
Presence of neutrophil-related PIDs is thought to be a major risk factor for development of periodontitis.
METHODS METHODS
This study had both a cross-sectional and cohort design. Twenty-four children (age 4-16) with PIDs and 24 age-matched systemically healthy subjects received a dental clinical examination, including measures of probing pocket depths (PPD), clinical attachment loss (CAL) and bleeding on probing (BOP). Those found to be affected by periodontal disease were offered periodontal treatment and reassessed 6 months later.
RESULTS RESULTS
Diagnosis of PIDs was associated with increased odds of presence of periodontal disease (p = .008 adjusted for age, gender, plaque, OR = 10.0, 95% CI = 1.83-54.38) and with continuous measures of periodontal disease such as number of PPDs >4 mm, mean PPD and mean CAL (all p < .001) and BOP (p = .001). However, only 7 out of 24 children were diagnosed with periodontitis. PIDs were also associated with a history of oral ulcers (p = .001, OR 12.47, 95% CI 2.71-57.29). An improvement in periodontal parameters (PPD and CAL) was detected following oral hygiene instructions and non-surgical periodontal therapy.
CONCLUSION CONCLUSIONS
Although children affected by neutrophil-associated PIDs exhibited a higher prevalence of periodontal disease compared with systemically healthy children, severe periodontitis was rarely seen. This suggests that good systemic control of the PIDs may reduce their impact on the periodontium.

Identifiants

pubmed: 33811759
doi: 10.1111/jre.12880
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-827

Informations de copyright

© 2021 The Authors. Journal of Periodontal Research published by John Wiley & Sons Ltd.

Références

Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.
Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr. 2010;20:16-34.
Szczawinska-Poplonyk A, Gerreth K, Breborowicz A, Borysewicz-Lewicka M. Oral manifestations of primary immune deficiencies in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e9-e20.
Halai H, Somani C, Donos N, Nibali L. Periodontal status of children with primary immunodeficiencies: a systematic review. Clin Oral Investig. 2020;24:1939-1951.
Nicu EA, Loos BG. Polymorphonuclear neutrophils in periodontitis and their possible modulation as a therapeutic approach. Periodontol 2000. 2016;71:140-163.
Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol. 2003;74:66-75.
Ghaffar KA, Rose-Nelson C, Glascoe A, Brown RS. Panoramic radiographic representation of progressive periodontal destruction in a family with six affected Papillon-Lefèvre siblings. J Clin Pediatr Dent. 2009;34:61-65.
Tomás I, Diz P, Tobías A, Scully C, Donos N. Periodontal health status and bacteraemia from daily oral activities: systematic review/meta-analysis. J Clin Periodontol. 2012;39:213-228.
Pernu HE, Pajari UH, Lanning M. The importance of regular dental treatment in patients with cyclic neutropenia. Follow-up of 2 cases. J Periodontol. 1996;67:454-459.
Kumar A, Masamatti SS, Virdi MS. Periodontal diseases in children and adolescents: a clinician's perspective part 2. Dent Update. 2012;39:639-652.
Okada M, Awane S, Suzuki J, et al. Microbiological, immunological and genetic factors in family members with periodontitis as a manifestation of systemic disease, associated with hematological disorders. J Periodontal Res. 2002;37:307-315.
Bimstein E, McIlwain M, Katz J, Jerrell G, Primosch R. Aggressive periodontitis of the primary dentition associated with idiopathic immune deficiency: case report and treatment considerations. J Clin Pediatr Dent. 2004;29:27-31.
Bailleul-Forestier I, Monod-Broca J, Benkerrou M, Mora F, Picard B. Generalized periodontitis associated with Chediak-Higashi syndrome. J Periodontol. 2008;79:1263-1270.
Nagendran J, Prakash C, Anandakrishna L, Gaviappa D, Ganesh D. Leukocyte adhesion deficiency: a case report and review. J Dent Child. 2012;79:105-110.
Sollecito TP, Sullivan KE, Pinto A, Stewart J, Korostoff J. Systemic conditions associated with periodontitis in childhood and adolescence. A review of diagnostic possibilities. Med Oral Patol Oral Cir Bucal. 2005;10:142-150.
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25:229-235.
dos Santos AP, Soviero VM. Comparison between two visible biofilm indices in the primary dentition. J Clin Pediatr Dent. 2006;30:292-295.
Biesbrock AR, Bartizek RD, Gerlach RW, Terézhalmy GT. Oral hygiene regimens, plaque control, and gingival health: a two-month clinical trial with antimicrobial agents. J Clin Dent. 2007;18:101-105.
Tonetti MS, Claffey N, European Workshop in Periodontology group C. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European workshop in periodontology. J Clin Periodontol. 2005;32(Suppl 6):210-213.
Sjödin B, Matsson L. Marginal bone level in the normal primary dentition. J Clin Periodontol. 1992;19:672-678.
Child Dental Health Survey. England, Wales and Northern Ireland - NHS Digital. 2013. https://digital.nhs.uk/data-and-information/publications/statistical/children-s-dental-health-survey/child-dental-health-survey-2013-england-wales-and-northern-ireland. Accessed March 14, 2020.
Peacock ME, Arce RM, Cutler CW. Periodontal and other oral manifestations of immunodeficiency diseases. Oral Dis. 2017;23:866-888.
Nickles K, Schacher B, Ratka-Krüger P, Krebs M, Eickholz P. Long-term results after treatment of periodontitis in patients with Papillon-Lefèvre syndrome: success and failure. J Clin Periodontol. 2013;40:789-798.
Arendorf TM, van der Ross R. Oral soft tissue lesions in a black pre-school South African population. Community Dent Oral Epidemiol. 1996;24:296-297.
Bessa CF, Santos PJ, Aguiar MC, do Carmo   MA. Prevalence of oral mucosal alterations in children from 0 to 12 years old. J Oral Pathol Med. 2004;33:17-22.
Majorana A, Bardellini E, Flocchini P, Amadori F, Conti G, Campus G. Oral mucosal lesions in children from 0 to 12 years old: ten years’ experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:e13-e18.
Amadori F, Bardellini E, Conti G, Majorana A. Oral mucosal lesions in teenagers: a cross-sectional study. Ital J Pediatr. 2017;43:50.
Porter SR, Luker J, Scully C, Oakhill A. Oral features of a family with benign familial neutropenia. J Am Acad Dermatol. 1994;30:877-880.
Hasturk H, Tezcan I, Yel L, et al. A case of chronic severe neutropenia: oral findings and consequences of short-term granulocyte colony-stimulating factor treatment. Aust Dent J. 1998;43:9-13.
Deas DE, Mackey SA, McDonnell HT. Systemic disease and periodontitis: manifestations of neutrophil dysfunction. Periodontol 2000. 2003;32:82-104.
Field EA, Brookes V, Tyldesley WR. Recurrent aphthous ulceration in children-a review. Int J Paediatr Dent. 1992;2:1-10.
MeR R-C, Planells-del Pozo P, Rioboo-García R. Epidemiology of the most common oral mucosal diseases in children. Med Oral Patol Oral Cir Bucal. 2005;10:376-387.
Natah SS, Häyrinen-Immonen R, Hietanen J, Malmström M, Konttinen YT. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med. 2000;29:19-25.
Sun A, Chu CT, Liu BY, Wang JT, Leu JS, Chiang CP. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers. Proc Natl Sci Counc Repub China B. 2000;24:116-122.
Scapini P, Cassatella MA. Social networking of human neutrophils within the immune system. Blood. 2014;124:710-719.
Hajishengallis G, Moutsopoulos NM, Hajishengallis E, Chavakis T. Immune and regulatory functions of neutrophils in inflammatory bone loss. Semin Immunol. 2016;28:146-158.
Ainamo J, Parviainen K, Murtomaa H. Reliability of the CPITN in the epidemiological assessment of periodontal treatment needs at 13-15 years of age. Int Dent J. 1984;34:214-218.

Auteurs

Luigi Nibali (L)

Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.
Department of Paediatric Dentistry, The Royal London Hospital, Barts Health NHS Trust, London, UK.

Josephine Bayliss-Chapman (J)

Centre for Oral Immunobiology & Regenerative Medicine & Centre for Oral Clinical Research, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

Hiten Halai (H)

Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.
Centre for Oral Immunobiology & Regenerative Medicine & Centre for Oral Clinical Research, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

Cheryl Somani (C)

Department of Paediatric Dentistry, The Royal London Hospital, Barts Health NHS Trust, London, UK.

Janet Davies (J)

Centre for Oral Bioengineering, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

Philip Ancliff (P)

Haematology & Oncology Department, Great Ormond Street Hospital for Children, London, UK.

Nikolaos Donos (N)

Centre for Oral Immunobiology & Regenerative Medicine & Centre for Oral Clinical Research, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH